Focuses on developing innovative therapies and technologies in the life sciences sector, emphasizing health improvement.
2005
United States
51 - 200 employees
Biotechnology
$1M - 10M in revenue
Not profitable
CO2e per visit (g)
Industry benchmark
Total Annual
Revenue & EBITDA
($ B)
Margin as % of revenue
R&D as % of revenue
Analyst consensus vs actuals
($ B)
0.0
▼ 73.8%
0.0
20250.9
2029Available
Available
Available
Available
4 out of 9 incl. management
Not available
Not available
Available
Not available
Not available
Not available
Not available